Not applicableStudy completedNCT01509391What this trial is testingKeyhole Limpet Hemocyanin in Chronic Hepatitis CWho this might be right forChronic Hepatitis CLiver Cirrhosis Medical University of Graz 14
Testing effectiveness (Phase 2)Looking for participantsNCT06920043What this trial is testingEfimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHWho this might be right forMetabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease GlaxoSmithKline 42
Not applicableActive Not RecruitingNCT06603311What this trial is testingFinite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV InfectionWho this might be right forCompensated Liver Disease (Disorder)Hepatitis D, Chronic Hannover Medical School 20
Large-scale testing (Phase 3)Looking for participantsNCT06419374What this trial is testingEvaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHWho this might be right forMetabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis 89bio, Inc. 762
Large-scale testing (Phase 3)Study completedNCT01939197What this trial is testingA Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionWho this might be right forHepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more AbbVie 318
Large-scale testing (Phase 3)Active Not RecruitingNCT03654053What this trial is testingMulti-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated CirrhosisWho this might be right forCirrhosis VA Office of Research and Development 142
Early research (Phase 1)Study completedNCT06525311What this trial is testingEvaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.Who this might be right forPrimary Biliary CholangitisCompensated Cirrhosis Kowa Research Institute, Inc. 17
Post-approval studies (Phase 4)Study completedNCT00467545What this trial is testingAn Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)UnknownNCT03067883What this trial is testingEfficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsWho this might be right forChronic Hepatitis c Ain Shams University 40
Large-scale testing (Phase 3)Study completedNCT03439254What this trial is testingStudy Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic SteatohepatitisWho this might be right forCompensated CirrhosisNonalcoholic Steatohepatitis Intercept Pharmaceuticals 919
Not applicableUnknownNCT05251272What this trial is testingA Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)Who this might be right forPortal Hypertension Hepatopancreatobiliary Surgery Institute of Gansu Province 300
Large-scale testing (Phase 3)Study completedNCT00131742What this trial is testingTelbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis
Large-scale testing (Phase 3)Study completedNCT03069365What this trial is testingEvaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal ImpairmentWho this might be right forHepatitis C Virus (HCV) AbbVie 101
Large-scale testing (Phase 3)Study completedNCT00057265What this trial is testingA Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BWho this might be right forChronic Hepatitis B Novartis
Post-approval studies (Phase 4)Looking for participantsNCT06449339What this trial is testingNon-selective Beta-blocker in Compensated Advanced Chronic Liver DiseaseWho this might be right forPortal HypertensionHepatic DecompensationAdvanced Chronic Liver Disease Chinese University of Hong Kong 474
Testing effectiveness (Phase 2)Looking for participantsNCT07219459What this trial is testingVisugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureWho this might be right forUnresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound CatalYm GmbH 104
Large-scale testing (Phase 3)Active Not RecruitingNCT05500222What this trial is testingEvaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)Who this might be right forNASHCirrhosis, Liver Madrigal Pharmaceuticals, Inc. 845
Not applicableUnknownNCT06397859What this trial is testingEffectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated CirrhosisWho this might be right forHepatitis D Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 266
Not applicableStudy completedNCT04557774What this trial is testingCognitive Function of Alcoholic Compensated Liver CirrhosisWho this might be right forAlcoholic Liver Disease Chuncheon Sacred Heart Hospital 110
Large-scale testing (Phase 3)UnknownNCT02732405What this trial is testingStudy to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated CirrhosisWho this might be right forHepatitis CCompensated Cirrhosis Istituto Clinico Humanitas 120